v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 393,644 $ 595,082
Tax incentive receivable 24,166 15,392
Prepaid expenses and other current assets 19,937 18,300
Total current assets 437,747 628,774
Property and equipment, net 1,168 162
Other non-current assets 5,392 699
Total assets 444,307 629,635
Current liabilities:    
Accounts payable 13,836 8,065
Accrued expenses and other current liabilities 24,502 16,573
Total current liabilities 38,338 24,638
Long term debt 69,800 75,700
Contingent value rights 0 37,700
Other non-current liabilities 0 43
Total liabilities 108,138 138,081
Commitments and contingencies (Note 7)
Shareholders’ equity    
Ordinary shares: £0.002 nominal value: 152,500,000 shares authorized; 94,843,391 shares issued and outstanding at December 31, 2022; 89,988,228 shares issued and outstanding at December 31, 2021 265 252
Additional paid-in capital 939,261 876,267
Accumulated other comprehensive (loss) income (1,497) 688
Accumulated deficit (601,860) (385,653)
Total shareholders’ equity 336,169 491,554
Total liabilities and shareholders’ equity $ 444,307 $ 629,635